SWIFT-seq, a novel blood test developed by researchers from the Dana-Farber Cancer Institute, may change the …
Tag:
Multiple Myeloma
-
-
The FDA maintained its momentum in July, issuing a wave of drug approvals across diverse therapeutic …
-
Health
FDA Panel Rejects Belantamab Mafodotin Combinations for Multiple Myeloma, Citing Safety Concerns
Belantamab mafodotin’s (Blenrep; GSK) return to the US market hit a significant hurdle as the FDA’s …
-
Isatuximab (Sarclisa; Sanofi), carfilzomib (Kyprolis; Onyx Pharmaceuticals), lenalidomide (Revlimid; Celgene Corporation), and dexamethasone induction yielded deep …
-
-
In an interview with Pharmacy TimesShaji Kumar, MD, consultant and research chair of the Division of …
-
-
“`html second Auto-SCT Improves Survival in Relapsed Multiple Myeloma Second Auto-SCT Improves Survival in Relapsed Multiple …
-
-
Health
Fred Hutch March 2025 News and Research: Chronic GVHD Prevention, Cancer Biomarker Discovery, Graduate Student Awards and Rare Skin Cancer Research
by drbyosby drbyosAdvancements and Trends in Cancer Research New Horizons in Graft-Vs.-Host Disease Prevention Graft-vs.-host disease (GVHD) remains …